CellAegis Devices Inc.

8 articles about CellAegis Devices Inc.

• CellAegis Devices Inc. Announces US$9.5 Million Financing To Support Clinical And Regulatory Advancement Of Its autoRIC Device

  3/14/2017

• CellAegis Devices Inc. Announces Second Clinical Program to Use the Company's Noninvasive autoRIC&#0153 Device for Chronic Remote Ischemic Conditioning (CRIC) Following Acute Myocardial Infarction (AMI)

  5/2/2013

• CellAegis Devices Inc. Receives Marketing Authorization From Health Canada for the AutoRIC&#0153 Device to Provide Non-Invasive Remote Ischemic Conditioning (RIC)

  3/7/2013

• CellAegis Devices Inc. Announces Clinical Program to Use the Company's Noninvasive AutoRIC&#0153 Device for Chronic Remote Ischemic Conditioning (CRIC) Following Acute Myocardial Infarction (AMI)

  2/27/2013

• CellAegis Devices Inc. Announces Initiation of Clinical Testing of Remote Ischemic Conditioning (RIC) Using the autoRIC™ Device for Patients Undergoing Partial Nephrectomy

  11/12/2012

• CellAegis Devices Inc. Announces First Clinical Program to Use the Company's autoRIC™ Device for Remote Ischemic Conditioning During Myocardial Infarction

  8/27/2012

• CellAegis Devices Inc. Expands Scientific Advisory Board With the Appointment of Sidney Levitsky, M.D.

  8/9/2012

• CellAegis Devices Inc. Receives CE Mark for autoRIC&#0153 Device in the European Union

  7/18/2012